Cargando…
Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia
BACKGROUND: Cancer cachexia is a multifactorial syndrome characterized by body weight loss and systemic inflammation. The characterization of the inflammatory response in patients with cachexia is still limited. Lipocalin-2, a protein abundant in neutrophils, has recently been implicated in appetite...
Autores principales: | Deng, Min, Aberle, Merel R., van Bijnen, Annemarie A. J. H. M., van der Kroft, Gregory, Lenaerts, Kaatje, Neumann, Ulf P., Wiltberger, Georg, Schaap, Frank G., Olde Damink, Steven W. M., Rensen, Sander S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057111/ https://www.ncbi.nlm.nih.gov/pubmed/37006254 http://dx.doi.org/10.3389/fimmu.2023.1159411 |
Ejemplares similares
-
Activation of the Complement System in Patients with Cancer Cachexia
por: Deng, Min, et al.
Publicado: (2021) -
Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer‐induced cachexia
por: Vaes, Rianne D.W., et al.
Publicado: (2020) -
Chemosensitivity of 3D Pancreatic Cancer Organoids Is Not Affected by Transformation to 2D Culture or Switch to Physiological Culture Medium
por: Gassl, Vincent, et al.
Publicado: (2022) -
Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids
por: Palzer, Julian, et al.
Publicado: (2021) -
Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids
por: Beelen, Nicky A., et al.
Publicado: (2023)